These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 3940664

  • 1. Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique.
    Ludmer PL, Wright RF, Arnold JM, Ganz P, Braunwald E, Colucci WS.
    Circulation; 1986 Jan; 73(1):130-7. PubMed ID: 3940664
    [Abstract] [Full Text] [Related]

  • 2. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
    Jaski BE, Fifer MA, Wright RF, Braunwald E, Colucci WS.
    J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
    [Abstract] [Full Text] [Related]

  • 3. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS, Wright RF, Jaski BE, Fifer MA, Braunwald E.
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [Abstract] [Full Text] [Related]

  • 4. Myocardial and vascular actions of milrinone.
    Colucci WS.
    Eur Heart J; 1989 Aug; 10 Suppl C():32-8. PubMed ID: 2680495
    [Abstract] [Full Text] [Related]

  • 5. Identification of the direct vasodilator effect of milrinone with an isolated limb preparation in patients with chronic congestive heart failure.
    Cody RJ, Müller FB, Kubo SH, Rutman H, Leonard D.
    Circulation; 1986 Jan; 73(1):124-9. PubMed ID: 3940663
    [Abstract] [Full Text] [Related]

  • 6. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure.
    Pflugfelder PW, O'Neill BJ, Ogilvie RI, Beanlands DS, Tanser PH, Tihal H, Mizgala HF, Fitchett DH, Kostuk WJ.
    Can J Cardiol; 1991 Jan; 7(1):5-10. PubMed ID: 2025794
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure.
    Baim DS, McDowell AV, Cherniles J, Monrad ES, Parker JA, Edelson J, Braunwald E, Grossman W.
    N Engl J Med; 1983 Sep 29; 309(13):748-56. PubMed ID: 6888453
    [Abstract] [Full Text] [Related]

  • 8. Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure.
    Monrad ES, Baim DS, Smith HS, Lanoue A, Brauwald E, Grossman W.
    Circulation; 1985 May 29; 71(5):972-9. PubMed ID: 3986984
    [Abstract] [Full Text] [Related]

  • 9. Observations on the intracoronary administration of milrinone and dobutamine to patients with congestive heart failure.
    Colucci WS.
    Am J Cardiol; 1989 Jan 03; 63(2):17A-22A. PubMed ID: 2909993
    [Abstract] [Full Text] [Related]

  • 10. Effects of intracoronary infusion of an inotropic agent, E-1020 (loprinone hydrochloride), on cardiac function: evaluation of left ventricular contractile performance using the end-systolic pressure-volume relationship.
    Murakami R, Sano K, Murakami Y, Shimada T, Morioka S.
    Int J Cardiol; 1995 Aug 03; 51(1):57-63. PubMed ID: 8522398
    [Abstract] [Full Text] [Related]

  • 11. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM, Hare JM, Loh E, Gauthier DF, Colucci WS.
    J Am Coll Cardiol; 1996 Dec 03; 28(7):1775-80. PubMed ID: 8962566
    [Abstract] [Full Text] [Related]

  • 12. Role of reflex sympathetic withdrawal in the hemodynamic response to an increased inotropic state in patients with severe heart failure.
    Arnold JM, Ludmer PL, Wright RF, Ganz P, Braunwald E, Colucci WS.
    J Am Coll Cardiol; 1986 Aug 03; 8(2):413-8. PubMed ID: 3734263
    [Abstract] [Full Text] [Related]

  • 13. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade.
    Travill CM, Pugh S, Noble MI.
    Clin Ther; 1994 Aug 03; 16(5):783-92. PubMed ID: 7859237
    [Abstract] [Full Text] [Related]

  • 14. Acute increase in exercise capacity with milrinone: lack of correlation with resting hemodynamic responses.
    Ribeiro JP, White HD, Hartley LH, Colucci WS.
    Braz J Med Biol Res; 1990 Aug 03; 23(11):1069-78. PubMed ID: 2133014
    [Abstract] [Full Text] [Related]

  • 15. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
    Mager G, Klocke RK, Kux A, Höpp HW, Hilger HH.
    Am Heart J; 1991 Jun 03; 121(6 Pt 2):1974-83. PubMed ID: 1852090
    [Abstract] [Full Text] [Related]

  • 16. The haemodynamic effects of milrinone HCl in halothane anaesthetised horses.
    Muir WW.
    Equine Vet J Suppl; 1995 Sep 03; (19):108-13. PubMed ID: 8933077
    [Abstract] [Full Text] [Related]

  • 17. Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.
    Maskin CS, Sinoway L, Chadwick B, Sonnenblick EH, Le Jemtel TH.
    Circulation; 1983 May 03; 67(5):1065-70. PubMed ID: 6831672
    [Abstract] [Full Text] [Related]

  • 18. Short-term assessment of left ventricular function, coronary hemodynamics, and catecholamine balance in severe congestive heart failure after a single oral dose of milrinone.
    Piscione F, Jaski BE, Serruys PW.
    J Cardiovasc Pharmacol; 1988 Mar 03; 11(3):258-69. PubMed ID: 2452918
    [Abstract] [Full Text] [Related]

  • 19. Comparative effects of inotropic agents on coronary and systemic hemodynamics of conscious dogs: actions of milrinone, dopamine, ouabain and MCI-154.
    Al-Wathiqui MH, Shimshak TM, Brooks HL, Preuss KC, Wynsen JC, Gross GJ, Warltier DC.
    Pharmacology; 1988 Mar 03; 36(4):217-27. PubMed ID: 3380877
    [Abstract] [Full Text] [Related]

  • 20. Effects of milrinone on systemic hemodynamics and regional circulations in dogs with congestive heart failure: comparison with dobutamine.
    Liang CS, Thomas A, Imai N, Stone CK, Kawashima S, Hood WB.
    J Cardiovasc Pharmacol; 1987 Nov 03; 10(5):509-16. PubMed ID: 2447398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.